NovoNorm Repaglinide Tablets Package Insert

Repaglinide Tablets is a medication used for the treatment of type 2 diabetes. It contains repaglinide as the main ingredient, which helps control blood sugar levels. It is suitable for adult diabetes patients who cannot effectively control high blood sugar through diet control, weight reduction, and exercise alone. Repaglinide Tablets can be used alone or in combination with metformin.


NovoNorm Repaglinide Tablets Package Insert - cover page
Brand
Novo Nordisk
Category
Other
Document type
Other
Language
Chinese
Pages
9
File format
PDF
File size
271 KB
Published
23 September, 2022
Updated
28 September, 2023
MD5 checksum
8ABC4030417CEF530B47D981722617A3

About this manual

This document is the official package insert (instruction leaflet) for NovoNorm Repaglinide Tablets, manufactured by Novo Nordisk. It provides comprehensive information regarding the drug's usage, dosage, indications, and safety profile for adult patients with Type 2 diabetes mellitus who require additional treatment alongside diet, weight reduction, and exercise. The text is written in Chinese and includes specific instructions on administration, such as taking the medication 15 minutes before meals, with available strengths of 0.5mg, 1.0mg, and 2.0mg.

The insert details the pharmacological properties, including metabolism via CYP2C8 and CYP3A4 enzymes, and highlights potential drug interactions, specifically warning against concurrent use with Gemfibrozil. It also lists common adverse reactions like hypoglycemia and provides guidelines for special patient populations, including those with liver or kidney impairment, as well as precautions for driving and operating machinery.

What's inside

  • 药品名称
  • 适应症
  • 规格
  • 用法用量
  • 不良反应
  • 禁忌
  • 注意事项
  • 药物相互作用
  • 药理毒理
  • 药代动力学

Specifications

Chemical FormulaC27H36N2O4
Molecular Weight452.6
Available Strengths0.5mg, 1.0mg, 2.0mg
Metabolism EnzymesCYP2C8, CYP3A4

Frequently asked questions

When should Repaglinide Tablets be taken?

The tablets should be taken 15 minutes before meals, or within 0-30 minutes before a meal.

What is the maximum recommended daily dose?

The maximum recommended daily dose should not exceed 16mg.

Can Repaglinide be used with Gemfibrozil?

No, Repaglinide and Gemfibrozil should not be used together due to significant increases in plasma drug concentration.

What is the most common adverse reaction?

The most common adverse reaction is hypoglycemia (low blood sugar).

Download PDF (271 KB)

More Novo Nordisk Manuals


View all Novo Nordisk manuals →